121 related articles for article (PubMed ID: 8282835)
1. Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction.
Raghavan C; Ditchfield J; Taylor RJ; Haeney MR; Barnes PC
J Clin Pathol; 1993 Dec; 46(12):1113-5. PubMed ID: 8282835
[TBL] [Abstract][Full Text] [Related]
2. [Anticardiolipin antibodies and early infarct of the myocardium].
Gaeta G; Lupoli S; Brancaccio V; Effuso L; Russo V; Boccalatte A
Cardiologia; 1998 Jul; 43(7):731-5. PubMed ID: 9738331
[TBL] [Abstract][Full Text] [Related]
3. Importance of serum anticardiolipin antibody levels in coronary heart disease.
Yilmaz E; Adalet K; Yilmaz G; Badur S; Erzengin F; Koylan N; Ozsaruhan O; Ertem G; Büyüköztürk K
Clin Cardiol; 1994 Mar; 17(3):117-21. PubMed ID: 8168279
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies in young myocardial infarction patients.
Mishra MN; Kalra R; Gupta MK
Indian J Biochem Biophys; 2007 Dec; 44(6):481-4. PubMed ID: 18320848
[TBL] [Abstract][Full Text] [Related]
5. Anticardiolipin antibodies in an unselected stroke population.
Muir KW; Squire IB; Alwan W; Lees KR
Lancet; 1994 Aug; 344(8920):452-6. PubMed ID: 7818647
[TBL] [Abstract][Full Text] [Related]
6. Anticardiolipin antibodies in patients with acute myocardial infarction.
Tsai RT; Wang CR; Lee GL; Chen MY; Lee YT; Chuang CY; Chen CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 May; 24(2):213-20. PubMed ID: 1855402
[TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin antibodies and lipoprotein (a) levels in patients with chronic renal failure treated with dialysis: associations with atherothrombotic disease.
Petersen LJ; Ringsdal VS; Ladefoged SD; Baslund B; Hansen PR
Int J Artif Organs; 1996 Jun; 19(6):339-42. PubMed ID: 8814496
[TBL] [Abstract][Full Text] [Related]
8. [Cardiolipin antibodies in patients with myocardial infarction and unstable angina pectoris].
Nasonov EL; Noeva EA; Kovalev VIu; Dragnev AG; Lopaeva OV; Ruda MIa
Kardiologiia; 1992 May; 32(5):32-4. PubMed ID: 1405256
[TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin antibodies in ischaemic heart disease: marker or myth?
Phadke KV; Phillips RA; Clarke DT; Jones M; Naish P; Carson P
Br Heart J; 1993 May; 69(5):391-4. PubMed ID: 8518060
[TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure.
Ozmen S; Danis R; Akin D; Batun S
Clin Nephrol; 2009 Sep; 72(3):193-8. PubMed ID: 19761724
[TBL] [Abstract][Full Text] [Related]
11. [Connections between ischemic heart disease and anti-cardiolipin antibody positivity].
Ferlazzo B; Bonanno D; Quattrocchi P; Paino AM; Arrigo F
Minerva Cardioangiol; 1993 Apr; 41(4):113-7. PubMed ID: 8332265
[TBL] [Abstract][Full Text] [Related]
12. Measuring of cardiolipin antibodies and plasma lipids in different stages of coronary disease.
Rebić R; Nastić-Mirić D; Pavlović S; Pokrajcić Z; Bosnjaković V
Med Pregl; 1993; 46 Suppl 1():20-2. PubMed ID: 8569595
[TBL] [Abstract][Full Text] [Related]
13. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
[TBL] [Abstract][Full Text] [Related]
14. Relation between left ventricular and/or left atrial thrombus and anticardiolipin antibodies in patients with acute myocardial infarction.
Güler N; Bilge M; Eryonucu B; Erkoç R; Sayarlioğlu M
Am J Cardiol; 2000 Jun; 85(11):1391-3. PubMed ID: 10831965
[No Abstract] [Full Text] [Related]
15. Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis.
Chuang FR; Chang HW; Lin CL; Wang IK; Chang HY; Wang PH; Yang CC; Chen TC; Wu CS; Lee CH
Int J Clin Pract; 2005 Jul; 59(7):785-90. PubMed ID: 15963205
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
[TBL] [Abstract][Full Text] [Related]
17. Anticardiolipin antibodies in rheumatoid arthritis: their relation to rheumatoid nodules and cutaneous vascular manifestations.
Wolf P; Gretler J; Aglas F; Auer-Grumbach P; Rainer F
Br J Dermatol; 1994 Jul; 131(1):48-51. PubMed ID: 8043421
[TBL] [Abstract][Full Text] [Related]
18. Anticardiolipin antibodies in patients with type 2 diabetes mellitus.
Calvo-Romero JM; Lima-Rodríguez EM
Clin Med Res; 2009 Sep; 7(3):93-5. PubMed ID: 19251581
[TBL] [Abstract][Full Text] [Related]
19. A case with epilepsy, cognitive impairment, renal microangiopathy and high titres of anticentromere and anticardiolipin antibodies.
Serelis J; Tektonidou MG; Skopouli FN
Lupus; 2005; 14(8):625-8. PubMed ID: 16175935
[TBL] [Abstract][Full Text] [Related]
20. A Comparitive Study of Anticardiolipin Antibodies among Systemic Lupus Erythematosus Patients from Western and Eastern India.
Doley D; Kakati S; Saikia L; Rajadhyaksha A; Nadkar M; Khadilkar P; Patwardhan M; Pradhan V
J Assoc Physicians India; 2017 Mar; 65(3):14-19. PubMed ID: 28462538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
